000 | 00984 a2200289 4500 | ||
---|---|---|---|
005 | 20250516160714.0 | ||
264 | 0 | _c20131028 | |
008 | 201310s 0 0 eng d | ||
022 | _a1555-2101 | ||
024 | 7 |
_a10.4088/JCP.12lr08004a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPhillips, Jennifer L | |
245 | 0 | 0 |
_aMs Phillips and Dr Blier reply. _h[electronic resource] |
260 |
_bThe Journal of clinical psychiatry _cJun 2013 |
||
300 |
_a631-2 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aBrain Diseases _xprevention & control |
650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
700 | 1 | _aBlier, Pierre | |
773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 74 _gno. 6 _gp. 631-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4088/JCP.12lr08004a _zAvailable from publisher's website |
999 |
_c22906371 _d22906371 |